Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01458184 · ClinicalTrials.gov registry record · NA

Study of PhoneCare System to Treat Patients With Chronic Diseases

A NA study, sponsored by Boston Medical Center.

Completed
Registry status
NA
Development phase
264
Enrollment target

NCT01458184: Completed NA study, sponsored by Boston Medical Center.

NCT01458184 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 264 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01458184, a NA study, has completed, sponsored by Boston Medical Center.

COMPLETED
Registry status
NA
Development phase
264 participants
Enrollment target

Study Summary

The aim of this study is to assess the effectiveness of Telephone-Linked Care for Complex Patients (TLC-C) in the care of patients with complex health care needs. These are patients frequently transitioning from inpatient to ambulatory care with multiple chronic diseases that tend to lead to increased health-care utilization and other socio-economic vulnerabilities. The objective is to reduce preventable hospital utilization, improve quality of life, increase satisfaction with ambulatory care, improve disease-specific metrics, and reduce net payer costs.

Interventions

  • BEHAVIORAL PhoneCare system

Trial Details

FieldValue
Enrollment Target 264 participants
Start Date 2008-09
Est. Completion 2013-04
Phase NA
Boston Medical Center

253 total trials

What the finished NCT01458184 record still lists

NCT01458184 is an interventional study that assigns participants to a tested intervention. The registered 264 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 1 intervention - of which PhoneCare system is the first listed.

NCT01458184 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01458184 about?

NCT01458184 is a clinical study titled "Study of PhoneCare System to Treat Patients With Chronic Diseases". The aim of this study is to assess the effectiveness of Telephone-Linked Care for Complex Patients (TLC-C) in the care of patients with complex health care needs. These are patients frequently transitioning from inpatient to ambulatory care with multiple chronic diseases that tend to lead to increas...

What is the current status of trial NCT01458184?

This trial is currently completed. It is a NA study. The enrollment target is 264 participants. The study started on 2008-09. Estimated completion is 2013-04.

What interventions are being tested in trial NCT01458184?

The interventions under investigation include: PhoneCare system (BEHAVIORAL).

Who is sponsoring clinical trial NCT01458184?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01458184's enrollment target sits among peer trials

264 395th of 2000 higher than 1,605 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04101669 · 264 participants · NA

    RESET System Pivotal Trial (Rev F)

  • NCT04295863 · 264 participants · Phase 1

    Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers

  • NCT05220202 · 264 participants · NA

    MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression

  • NCT05473013 · 264 participants · NA

    Optimizing Digital Health Technology Interventions to Increase Skill Acquisition and Utilization

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01458184, the US trial registry maintained by the National Library of Medicine. NCT01458184 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.